Episode Description
“Legal issues intersect with non-legal issues in [the] 340B space,” says Brandon Shirley, a partner at Krieg DeVault, who teams up with Jason Prokopik, PharmD, Senior Manager & Pharmacy Consultant at Blue & Co., LLC to host this rapid-fire 340B review. Following the 340B Coalition Conference in San Diego in February 2026, they tackled five hot topics: the CMS Medicare survey for 340B hospitals; a court ruling regarding child site activation; the status of the rebate model pilot; Indiana's new mandatory 340B reporting requirement and the proposed Indiana Medicaid restrictions on 340B drug submissions; and a Ninth Circuit False Claims Act ruling against drug manufacturers. Tune in to learn more about each of these developments.
Connect and Learn More
☑️ Blue & Co., LLC | LinkedIn | X | Facebook | Instagram
☑️ Brandon Shirley | LinkedIn
☑️ Krieg DeVault LLP | LinkedIn | X | Facebook
☑️ Subscribe Apple Podcasts | Spotify | Amazon Music